メディシノバ・インクの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2018/12/12 | 1,010 | 1,044 | 1,007 | 1,038 | +54 | +5.5% | 91,600 |
2018/12/11 | 988 | 1,007 | 974 | 984 | +4 | +0.4% | 147,700 |
2018/12/10 | 1,020 | 1,034 | 963 | 980 | -51 | -4.9% | 236,400 |
2018/12/07 | 1,078 | 1,078 | 1,024 | 1,031 | -24 | -2.3% | 104,400 |
2018/12/06 | 1,088 | 1,100 | 1,033 | 1,055 | -44 | -4% | 166,700 |
2018/12/05 | 1,092 | 1,117 | 1,080 | 1,099 | +8 | +0.7% | 120,200 |
2018/12/04 | 1,103 | 1,124 | 1,088 | 1,091 | -13 | -1.2% | 154,200 |
2018/12/03 | 1,120 | 1,125 | 1,091 | 1,104 | -16 | -1.4% | 150,600 |
2018/11/30 | 1,133 | 1,150 | 1,100 | 1,120 | -25 | -2.2% | 117,500 |
2018/11/29 | 1,149 | 1,156 | 1,132 | 1,145 | +16 | +1.4% | 115,600 |
2018/11/28 | 1,140 | 1,147 | 1,123 | 1,129 | -20 | -1.7% | 92,300 |
2018/11/27 | 1,133 | 1,157 | 1,119 | 1,149 | +45 | +4.1% | 149,600 |
2018/11/26 | 1,098 | 1,109 | 1,077 | 1,104 | +25 | +2.3% | 83,200 |
2018/11/22 | 1,064 | 1,095 | 1,046 | 1,079 | +22 | +2.1% | 114,300 |
2018/11/21 | 1,055 | 1,079 | 1,046 | 1,057 | -34 | -3.1% | 162,100 |
2018/11/20 | 1,100 | 1,110 | 1,089 | 1,091 | -26 | -2.3% | 90,400 |
2018/11/19 | 1,075 | 1,137 | 1,072 | 1,117 | +3 | +0.3% | 167,000 |
2018/11/16 | 1,136 | 1,149 | 1,100 | 1,114 | -23 | -2% | 87,900 |
2018/11/15 | 1,085 | 1,145 | 1,082 | 1,137 | ±0 | ±0% | 139,900 |
2018/11/14 | 1,158 | 1,180 | 1,131 | 1,137 | +8 | +0.7% | 156,400 |
2018/11/13 | 1,051 | 1,175 | 1,051 | 1,129 | +28 | +2.5% | 274,500 |
2018/11/12 | 1,153 | 1,169 | 1,097 | 1,101 | -96 | -8% | 344,100 |
2018/11/09 | 1,210 | 1,233 | 1,180 | 1,197 | -50 | -4% | 359,500 |
2018/11/08 | 1,350 | 1,355 | 1,235 | 1,247 | -86 | -6.5% | 601,700 |
2018/11/07 | 1,315 | 1,377 | 1,309 | 1,333 | +34 | +2.6% | 371,500 |
2018/11/06 | 1,210 | 1,300 | 1,210 | 1,299 | +93 | +7.7% | 247,600 |
2018/11/05 | 1,198 | 1,235 | 1,196 | 1,206 | +9 | +0.8% | 115,100 |
2018/11/02 | 1,205 | 1,221 | 1,180 | 1,197 | +12 | +1% | 188,400 |
2018/11/01 | 1,100 | 1,224 | 1,073 | 1,185 | +85 | +7.7% | 167,500 |
2018/10/31 | 1,079 | 1,115 | 1,061 | 1,100 | +64 | +6.2% | 200,600 |
2018/10/30 | 990 | 1,068 | 983 | 1,036 | +11 | +1.1% | 230,400 |
2018/10/29 | 1,050 | 1,070 | 1,005 | 1,025 | -16 | -1.5% | 142,600 |
2018/10/26 | 1,050 | 1,068 | 991 | 1,041 | +23 | +2.3% | 249,500 |
2018/10/25 | 1,049 | 1,085 | 1,009 | 1,018 | -151 | -12.9% | 504,600 |
2018/10/24 | 1,145 | 1,173 | 1,102 | 1,169 | +29 | +2.5% | 225,900 |
2018/10/23 | 1,185 | 1,205 | 1,139 | 1,140 | -54 | -4.5% | 205,800 |
2018/10/22 | 1,181 | 1,206 | 1,155 | 1,194 | -18 | -1.5% | 238,500 |
2018/10/19 | 1,218 | 1,223 | 1,182 | 1,212 | -38 | -3% | 253,300 |
2018/10/18 | 1,284 | 1,284 | 1,248 | 1,250 | -28 | -2.2% | 106,300 |
2018/10/17 | 1,309 | 1,309 | 1,278 | 1,278 | -1 | -0.1% | 114,900 |
2018/10/16 | 1,290 | 1,295 | 1,265 | 1,279 | -3 | -0.2% | 78,200 |
2018/10/15 | 1,273 | 1,300 | 1,240 | 1,282 | +12 | +0.9% | 153,100 |
2018/10/12 | 1,184 | 1,286 | 1,183 | 1,270 | +58 | +4.8% | 192,900 |
2018/10/11 | 1,196 | 1,245 | 1,150 | 1,212 | -95 | -7.3% | 517,200 |
2018/10/10 | 1,355 | 1,392 | 1,296 | 1,307 | -70 | -5.1% | 338,100 |
2018/10/09 | 1,373 | 1,404 | 1,354 | 1,377 | -51 | -3.6% | 239,300 |
2018/10/05 | 1,382 | 1,471 | 1,368 | 1,428 | +34 | +2.4% | 400,400 |
2018/10/04 | 1,400 | 1,418 | 1,388 | 1,394 | -8 | -0.6% | 123,400 |
2018/10/03 | 1,410 | 1,420 | 1,368 | 1,402 | -40 | -2.8% | 240,900 |
2018/10/02 | 1,470 | 1,478 | 1,418 | 1,442 | -35 | -2.4% | 323,300 |
1601~
1650
件表示中 / 3737件
類似銘柄と比較する
現在ご覧いただいている「メディシノバ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
メディシノバ | 18,500円 | - | - | - | - | - |
|
- |
ソレイジア | 4,400円 | +311.4% | - | 0.00% | - | 8.45倍 |
|
がん柱の創薬ベンチャー。候補品導入後に開発進め権利再導出、製品販売を行うビジネスモデル |
NANO | 13,800円 | -30.6% | - | 0.00% | - | 3.58倍 |
|
mRNA医薬品に特化した創薬ベンチャー。創薬シーズ発掘から臨床開発まで手がけて導出 |
仁 丹 | 212,100円 | +0.3% | +9.2% | 3.06% | 12.05倍 | 0.71倍 |
|
代名詞の仁丹から整腸作用軸に健康サプリ、医薬品へ展開。シームレスカプセル技術に特長 |
シンバイオ | 17,100円 | -42.9% | - | 0.00% | - | 2.15倍 |
|
導入で新薬開発・製品化。抗がん剤「トレアキシン」国内販売。抗ウイルス薬BCVの開発に注力 |
市場注目の銘柄
チャート関連のコラム